Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the Coordinating Center's results

Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the Coordinating Center's results

AIM. To make a randomized comparison of 2 consolidation treatment options (two patient groups): 2 cycles of cytarabine in average (1g/m2 in Group 2) and standard (100 mg/m2 in Group 1) doses in combination with idarubicin (8-12 mg/m2) and mitoxantrone (10 mg/m2), after two 7+3 induction cycles of da...

Full description

Bibliographic Details
Main Authors: E N Parovichnikova, V V Troitskaia, G A Kliasova, L A Kuz'mina, A N Sokolov, E V Paramonova, G M Galstian, S A Kessel'man, M Iu Drokov, V A Vasil'eva, T N Obukhova, S M Kulikov, V G Savchenko
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2014-07-01
Series:Терапевтический архив
Subjects:
acute myeloid leukemia
randomization
multicenter trial
allogeneic bone marrow transplantation
Online Access:https://ter-arkhiv.ru/0040-3660/article/view/31510

Internet

https://ter-arkhiv.ru/0040-3660/article/view/31510

Similar Items